>>Signaling Pathways>> Neuroscience>> Ophthalmology>>Methylatropine (nitrate)

Methylatropine (nitrate) (Synonyms: Atropine methyl nitrate)

Catalog No.GC48661

A muscarinic acetylcholine receptor antagonist

Products are for research use only. Not for human use. We do not sell to patients.

Methylatropine (nitrate) Chemical Structure

Cas No.: 52-88-0

Size 가격 재고 수량
5mg
US$94.00
재고 있음
25mg
US$259.00
재고 있음
50mg
US$472.00
재고 있음
100mg
US$848.00
재고 있음

Tel:(909) 407-4943 Email: sales@glpbio.com

고객 리뷰

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents

Methylatropine is an antagonist of muscarinic acetylcholine receptors (IC50 = <0.1 nM in a radioligand binding assay using isolated porcine brain membranes) and a derivative of atropine .1,2 It reduces acetylcholine-induced decreases in blood pressure in rats when administered intravenously with an ED50 value of 5.5 µg/kg.2 Methylatropine reduces salivation, induces mydriasis, and increases heart rate in dogs.3

1.Schmeller, T., Sporer, F., Sauerwein, M., et al.Binding of tropane alkaloids to nicotinic and muscarinic acetylcholine receptorsPharmazie50(7)493-495(1995) 2.Brezenoff, H.E., Xiao, Y.-F., and Vargas, H.A comparison of the central and peripheral antimuscarinic effects of atropine and methylatropine injected systemically and into the cerebral ventriclesLife Sci.42(8)905-911(1988) 3.Albanus, L.Central and peripheral effects of anticholinergic compoundsActa Pharmacol. Toxicol. (Copenh)28(4)305-326(1970)

리뷰

Review for Methylatropine (nitrate)

Average Rating: 5 ★★★★★ (Based on Reviews and 11 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Methylatropine (nitrate)

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.